PRONOXIS
ProNoxis develops, produces and markets novel treatments for autoimmune disorders where modification of NADPH oxidase (NOX2) activity is one key for diseases like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease (IBD). ProNoxis is a spin-out from Redoxis.
PRONOXIS
Industry:
Biotechnology
Founded:
2009-01-01
Address:
Göteborg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.pronoxis.com
Total Employee:
1+
Status:
Active
Contact:
46-709-164608
Technology used in webpage:
Viewport Meta Google Font API Google Maps Mobile Optimized Shutterstock One.com Website Builder
Similar Organizations
Atlas Antibodies
Atlas Antibodies develops, produces, and globally markets and sells advanced reagents for biomedical research.
GS Environnement
GS Environnement designs, develops, produces, and markets new technologies for professional kitchens.
Investors List
Karolinska
Karolinska investment in Venture Round - ProNoxis
Lund University Bioscience
Lund University Bioscience investment in Venture Round - ProNoxis
Official Site Inspections
http://www.pronoxis.com
- Host name: webcluster2.webpod12-cph3.one.com
- IP address: 46.30.213.40
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "ProNoxis"
ProNoxis - Crunchbase Company Profile & Funding
Organization. ProNoxis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... ProNoxis is a spin-out from Redoxis. Lists Featuring …See details»
Management | pronoxis.com
Since May 2016, Dr. Olofsson is the CEO of ProNoxis AB, providing exoertice in preclinical drug development and international pattnerships and IP management. Peter was between 2007 …See details»
ProNoxis Company Profile 2024: Valuation, Investors ... - PitchBook
ProNoxis is a Private company. What is ProNoxis’s current revenue? The current revenue for ProNoxis is . How much funding has ProNoxis raised over time? ProNoxis has raised $637K. …See details»
ProNoxis - Overview, News & Similar companies | ZoomInfo.com
ProNoxis AB was founded in 2009 by LU Bioscience AB (LUBio), Karolinska Development AB, and Redoxis AB, as a Redoxis spin-off focusing on developin g anti-inflammatory therapeutics …See details»
ProNoxis - Funding, Financials, Valuation & Investors - Crunchbase
Jun 1, 2009 ProNoxis has raised 1 round. This was a Venture - Series Unknown round raised on Jun 1, 2009. ProNoxis is funded by 2 investors. Karolinska and Lund University Bioscience are …See details»
ProNoxis - VentureRadar
Similar Companies: Guilded Unknown Privately Held Guilded is the ultimate chat platform for gaming communities. Founded in 2017 by Eli Brown, a former pro gamer who played an …See details»
Pronoxis AB Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Pronoxis AB of Trollhättan, Västra Götaland. Get the latest business insights from Dun & Bradstreet.See details»
Pronoxis - Company Profile - Tracxn
Pronoxis - Small molecule therapeutics for chronic inflammation. Raisedfunding over 2 rounds from 2 investors. Pronoxis has 303 competitors.See details»
ProNoxis Company Profile - Office Locations, Competitors ... - Craft
ProNoxis has 1 employees at their 1 location. See insights on ProNoxis including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
ProNoxis AB:Company Profile & Technical Research,Competitor …
ProNoxis is a company that provides Clinical trial, Medicine, NADPH oxidase and more. ProNoxis is headquartered in Sweden Vastra Gotaland. ProNoxis was founded in 2009. ProNoxis has a …See details»
ProNoxis - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 ProNoxis uses 6 technology products and services including HTML5, Google Fonts, and Apache Server, according to G2 Stack. ProNoxis is actively using 3 technologies …See details»
Pronoxis - Products, Competitors, Financials, Employees, …
Pronoxis is a biotechnology company specializing in the preclinical discovery of small-molecule drugs within the pharmaceutical industry. The company's main focus is on developing …See details»
ProNoxis AB - VentureRadar
ProNoxis is developing new small molecules for the treatment of chronic inflammation, such as rheumatoid arthritis, multiple sclerosis and abdominal inflammation. VentureRadar Research / …See details»
News | pronoxis.com
2024-03-13. Pronoxis ownerhip changes. The CRO company Redoxis have as result of more focused strategy for research services and expension as international recognised CRO, …See details»
ProNoxis AB - Lund, Sweden - bionity.com
ProNoxis develops, produces and markets novel treatments for autoimmune disorders where modification of NADPH oxidase (NOX2) activity is one key for diseases like rheumatoid …See details»
Contact | pronoxis.com
Please contact us if you are interested in collaborating with Pronoxis and testing our small molecules in your models. Contact Pronoxis +46 (0)709 16 46 08. …See details»
Codexis, Inc. (LON: 0I0X) Stock Price & Overview - Stock Analysis
5 days ago Financial Performance. In 2023, Codexis's revenue was $70.14 million, a decrease of -49.39% compared to the previous year's $138.59 million. Losses were -$76.24 million, …See details»
Research | pronoxis.com
ProNoxis develops products for the treatment of autoimmune, inflammatory and infectious diseases characterized by a large unmet medical need and either large patient populations or …See details»
Research - Pronoxis
ProNoxis Research Our mission is to develop a suitable drug for oral administration in human patients suffering from autoimmune inflammatory disease. Autoimmune diseases are …See details»